Literature DB >> 8615258

Abdominopelvic MR imaging in the nonobstetric evaluation of pregnant patients.

R Forstner1, C L Kalbhen, R A Filly, H Hricak.   

Abstract

Managing a pregnant patient with a suspected nonobstetric abdominopelvic disorder is challenging. Information from imaging affects the treatment options, which range from operating emergently and risking miscarriage to terminating the pregnancy or delaying treatment until after delivery. The most common indications for MR imaging during pregnancy are disorders of the central nervous and cardiovascular systems. In the evaluation of the abdomen and pelvis, sonography plays the pivotal role; however, sonography may be inconclusive because of its limited specificity in tissue characterization and technical difficulties caused by the enlarged uterus. For these reasons MR imaging has emerged as a valuable adjunct to sonography. In this pictorial essay we describe a variety of nonobstetric abdominopelvic disorders during pregnancy in which MR imaging contributed to patient management.

Entities:  

Mesh:

Year:  1996        PMID: 8615258     DOI: 10.2214/ajr.166.5.8615258

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

Review 1.  Risks to the fetus from diagnostic imaging during pregnancy: review and proposal of a clinical protocol.

Authors:  Mafalda Gomes; Alexandra Matias; Filipe Macedo
Journal:  Pediatr Radiol       Date:  2015-08-14

2.  Sciatica in the female patient: anatomical considerations, aetiology and review of the literature.

Authors:  Abdul-Wahab T Al-Khodairy; Philippe Bovay; Charles Gobelet
Journal:  Eur Spine J       Date:  2006-04-19       Impact factor: 3.134

3.  Cecal volvulus in pregnancy: report of a case and review of the safety and utility of medical diagnostic imaging in the assessment of the acute abdomen during pregnancy.

Authors:  Brian A Hogan; Carl J Brown; Jacqueline A Brown
Journal:  Emerg Radiol       Date:  2007-07-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.